A Pilot Study to Assess the Feasibility and Acceptability of Newborn Screening Using in Silico Panel-based Solo Genome Sequencing in France

Abroad (travel likely)Recruiting

Conditions

Newborn Screening Programmes for Rare Diseases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHU d'Angers, Angers, France
Contact: Study coordinator (Estelle COLIN) · escolin@chu-angers.fr · 0241353470
CHU Besançon, Besançon, France
Contact: Study coordinator (Nicolas MOTTET) · N1mottet@chubesancon.fr · 0381218505
CHU Dijon Bourgogne, Dijon, France
Contact: Study coordinator (Laurence OLIVIER-FAIVRE) · laurence.faivre@chu-dijon.fr · 0380295313
CHU Hôtel Dieu, Nantes, France
Contact: Study coordinator (Sandra MERCIER) · sandra.mercier@chu-nantes.fr · 0240083245
CHU Rennes - Hôpital Sud, Rennes, France
Contact: Study coordinator (Laurent PASQUIER) · laurent.pasquier@chu-rennes.fr · 0299266744

View source on ClinicalTrials.gov